Key Financial Data Of Group

OncoTherapy Science, Inc. - Filing #7595079

Concept 2022-04-01 to
2022-06-30
As at
2022-06-30
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of group
Business results of group
Ordinary profit (loss)
-314,093,000 JPY
-2,071,783,000 JPY
-571,509,000 JPY
Profit (loss) attributable to owners of parent
-277,799,000 JPY
-2,571,541,000 JPY
-534,929,000 JPY
Comprehensive income
-277,799,000 JPY
-2,571,541,000 JPY
-534,929,000 JPY
Net assets
1,669,297,000 JPY
1,980,233,000 JPY
3,200,978,000 JPY
Total assets
2,042,544,000 JPY
2,685,199,000 JPY
3,595,376,000 JPY
Basic earnings (loss) per share
-1.44
-13.72
-3.00
Diluted earnings per share
Equity-to-asset ratio
0.793 xbrli:pure
0.706 xbrli:pure
0.876 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.